Canada promotes research on alternative treatments for breast cancer

D Holzman - Alternative and Complementary Therapies, 1998 - liebertpub.com
… , alternative medicine emerged as an important issue in Canadian breast cancer research. …
cancer research institute, has been one of the primary backers of hydrazine sulfate. Dr. Gold …

… of the National Workshop on Research Methodologies for Unconventional Therapies, Sponsored by the Canadian Breast Cancer Research Initiative (CBCRI), Held …

JS Jacobson - … Journal of Alternative and Complementary Medicine, 1996 - liebertpub.com
Medicine, and practitioners nous healing systems are represented in these of complementary
therapies … How can we create a natural extension of the groundwork laid at in our medical …

Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer

, … Oncology Guidelines Working Group - … Cancer Institute …, 2014 - academic.oup.com
… of participants had breast cancer and/or breast cancer patient results … of the US Preventive
Services Task Force grading system. … Alternative medicine is the use of a therapy in place of …

Complementary and alternative medicine in breast cancer patients

Z Nahleh, IA Tabbara - Palliative & supportive care, 2003 - cambridge.org
… Alternative care: Patient choices for adjunct therapies within a cancer center. … The use of
complementary therapies by breast cancer patients attending conventional treatment. European …

Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment

H Greenlee, MJ DuPont‐Reyes… - CA: a cancer journal …, 2017 - Wiley Online Library
Complementary and alternative therapies are generally defined as … by the US Preventive
Services Task Force10 to develop graded … process outlined by the Institute of Medicine,11 drafts …

[PDF][PDF] Research on complementary/alternative medicine for patients with breast cancer: a review of the biomedical literature

JS Jacobson, SB Workman… - Journal of Clinical …, 2000 - columbia.akadns.net
Institutes of Health Office of Alternative Medicine, now the National Center for Complementary
and Alternative Medicine.… , although their association with cancer progression and survival …

Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM)

LG Balneaves, TLO Truant, M Kelly, MJ Verhoef… - … Care in Cancer, 2007 - Springer
… of this study was to explore the personal and social processes women with breast cancer
Funding for this project was received from the Canadian Institutes of Health Research (CIHR…

… ovarian ablation for metastatic breast cancer in premenopausal women: a report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA …

CA Sawka, KI Pritchard, W Shelley, G DeBoer… - Breast cancer research …, 1997 - Springer
… an earlier change in therapy. The guidelines of the Breast Cancer Task Force [15] were …
(SD) after eight weeks of treatment were continued on first-line therapy until the time of overt …

[PDF][PDF] Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: a Cancer Care Ontario and American Society of Clinical Oncology clinical …

S Dhesy-Thind, GG Fletcher, PS Blanchette… - J Clin …, 2017 - medicalrp.com.mx
… ) be considered as adjuvant therapy for postmenopausal patients with breast cancer who
are deemed candidates for adjuvant systemic therapy. Further research comparing different …

Lapatinib or trastuzumab plus taxane therapy for human epidermal growth factor receptor 2–positive advanced breast cancer: final results of NCIC CTG MA. 31

KA Gelmon, FM Boyle, B Kaufman… - Journal of Clinical …, 2015 - ascopubs.org
treating patients whose breast cancers overexpress the ErbB2 protein or demonstrate ErbB2
gene amplification. It is currently being tested in combination with other therapies. … institution